Why is Medicamen Biotec falling/rising?

As of 03-Sep, Medicamen Biotech Ltd's stock price is currently at Rs. 350.00, reflecting a slight increase of 0.2 (0.06%). The stock has been gaining over the past three days, with a total return of 1.83% during this period. However, it recently hit a new 52-week low of Rs. 341.2 today, indicating ongoing challenges. The stock has underperformed its sector by 1.18% today and has shown a significant decline of 31.27% year-to-date, contrasting sharply with the Sensex, which has gained 3.11% in the same timeframe. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 61.05% compared to the 5-day average, which may contribute to the stock's volatility.
Broader market context reveals that while Medicamen Biotech has experienced a slight uptick in the short term, its overall performance remains concerning when viewed against the benchmark. Over the past week, the stock has gained 0.30%, whereas the Sensex has declined by 0.27%. This indicates that despite recent gains, the stock is struggling to keep pace with broader market trends, which may be affecting investor sentiment. The stock's moving averages suggest that it is currently performing better than the 5-day average but is still lagging behind longer-term averages, further highlighting the challenges it faces in regaining investor confidence.